triphenyltetrazolium has been researched along with 1,5-dihydroxyisoquinoline in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hanif, K; Sharma, G; Singh, N | 1 |
1 other study(ies) available for triphenyltetrazolium and 1,5-dihydroxyisoquinoline
| Article | Year |
|---|---|
A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Brain; Brain Edema; Coloring Agents; Drug Therapy, Combination; Infarction, Middle Cerebral Artery; Isoquinolines; Male; Neuroprotective Agents; Neuropsychological Tests; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reactive Oxygen Species; Tetrazoles; Tetrazolium Salts | 2014 |